(Bloomberg) -- Iceland is joining its Nordic peers in halting inoculations with Moderna Inc.’s Spikevax shot on concern over side effects.
The Moderna jab, which has mostly been used in Iceland for second doses, won’t be used until more information over its safety has been collected, the chief epidemiologist said on Friday.
Sweden, Denmark and Finland have this week suspended the jabs for younger people because of the risk of heart inflammation as a potential side effect. Norway said men under 30 should consider choosing the Pfizer Inc.’s and BioNTech SE’s rival vaccine, and the other Nordic nations also recommended that as an alternative. Both vaccinations use messenger RNA technology to prompt an immune reaction.
©2021 Bloomberg L.P.
BNN Bloomberg Picks
Amazon to buy Roomba-maker IRobot for US$1.65B
BCE CEO sees Q3 boost from Rogers customers jumping ship
Were you affected by recent job cuts in the tech sector? We want to hear from you
'Wait and see': Toronto, Vancouver home sales plummet as buyers hang around
$40M Quebec mansion hits market as luxury home sales brush off higher rates
Cheap date? Finding 'the one' on a budget when everything costs more